| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $105.08M | - | |
| Dir | 1.55M | $83.07M | - | |
| Dir | 1.19M | $63.60M | - | |
| CFO | 1.12M | $59.75M | - | |
| VP | 594.7K | $31.81M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2018 | Wyszomierski Jack L | Director | Sale+OE | 14,959 | $20.25 | $302,919.75 | -13.7% | |
| Apr 16, 2018 | Garber Alan M50 | Director | Sale+OE | 15,000 | $20.25 | $303,750.00 | -19.7% | |
| Apr 11, 2018 | Morrissey Michael | President And CEO | Sale+OE | 90,000 | $20.78 | $1,870,200.00 | -40.6% | |
| Mar 6, 2018 | Marchesi Vincent T | Director | Sale+OE | 15,000 | $24.73 | $370,950.00 | -10.6% | |
| Mar 5, 2018 | Cohen Charles | Director | Sale+OE | 15,000 | $24.23 | $363,450.00 | -5.7% | |
| Mar 5, 2018 | Feldbaum Carl B47 | Director | Sale+OE | 11,000 | $23.88 | $262,680.00 | -24.1% | |
| Mar 2, 2018 | Willsey Lance | Director | Sale+OE | 30,000 | $23.91 | $717,300.00 | -6.0% | |
| Mar 2, 2018 | Papadopoulos Stelios53 | Director | Sale+OE | 15,000 | $24.05 | $360,750.00 | -1.4% | |
| Feb 28, 2018 | Poste George | Director | Sale+OE | 15,000 | $26.26 | $393,900.00 | -15.2% | |
| Feb 28, 2018 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sale+OE | 45,029 | $27.13 | $1,221,636.77 | -28.4% |